ONWARD Medical NV (Euronext: ONWD), a medical technology company behind innovative therapies* focused on restoring movement, function and independence to patients living with spinal cord injury, today announced that the 2024 general meeting of its shareholders (AG) will be held in the Dutch capital on June 13, 2024.
On this occasion, the Company will submit a series of resolutions for deliberation.
The Board of Directors aims to adopt the measures detailed in the attached press release.
The registration deadline is May 16, 2024 for any shareholder wishing to participate in the AGM.
The notice of meeting, the complete agenda and all other details relating to the 2024 AGM, as well as all related documents are available on the Company’s website, in the chapter dedicated to financial information in the Investors section (www.ir.onwd.com) and made available to shareholders in accordance with the legal framework from May 2, 2024.
Find the full press release, attached.
Contact for Public Relations in France for ONWARD Medical: Gabriel Rafaty, Aimpact _ [email protected]